Burcon NutraScience Valuation
| BU Stock | CAD 1.69 0.09 5.06% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Burcon NutraScience shows a prevailing Real Value of C$1.59 per share. The current price of the firm is C$1.69. Our model approximates the value of Burcon NutraScience from analyzing the firm fundamentals such as Return On Equity of -12.46, operating margin of (8.13) %, and Shares Outstanding of 12.69 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Burcon NutraScience's valuation include:
Price Book 5.9696 | Enterprise Value | Enterprise Value Ebitda (2.57) | Price Sales 26.6799 | Forward PE 454.5455 |
Overvalued
Today
Please note that Burcon NutraScience's price fluctuation is dangerous at this time. Calculation of the real value of Burcon NutraScience is based on 3 months time horizon. Increasing Burcon NutraScience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Burcon NutraScience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Burcon Stock. However, Burcon NutraScience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.69 | Real 1.59 | Hype 1.69 | Naive 1.57 |
The intrinsic value of Burcon NutraScience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Burcon NutraScience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Burcon NutraScience helps investors to forecast how Burcon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Burcon NutraScience more accurately as focusing exclusively on Burcon NutraScience's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Burcon NutraScience's intrinsic value based on its ongoing forecasts of Burcon NutraScience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Burcon NutraScience's closest peers.
Burcon NutraScience Cash |
|
Burcon NutraScience Total Value Analysis
Burcon NutraScience is currently anticipated to have takeover price of 22.58 M with market capitalization of 21.44 M, debt of 22.4 M, and cash on hands of 1.46 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Burcon NutraScience fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.58 M | 21.44 M | 22.4 M | 1.46 M |
Burcon NutraScience Investor Information
About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.15. Burcon NutraScience had not issued any dividends in recent years. The entity had 1:20 split on the 11th of June 2025. Based on the measurements of operating efficiency obtained from Burcon NutraScience's historical financial statements, Burcon NutraScience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Burcon NutraScience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Burcon NutraScience has an asset utilization ratio of 1.24 percent. This suggests that the Company is making C$0.0124 for each dollar of assets. An increasing asset utilization means that Burcon NutraScience is more efficient with each dollar of assets it utilizes for everyday operations.Burcon NutraScience Ownership Allocation
The market capitalization of Burcon NutraScience is C$21.44 Million. Burcon NutraScience retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Burcon NutraScience Profitability Analysis
The company reported the revenue of 381.4 K. Net Loss for the year was (8.26 M) with loss before overhead, payroll, taxes, and interest of (3.96 M).About Burcon NutraScience Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Burcon NutraScience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Burcon NutraScience based exclusively on its fundamental and basic technical indicators. By analyzing Burcon NutraScience's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Burcon NutraScience's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Burcon NutraScience. We calculate exposure to Burcon NutraScience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Burcon NutraScience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1 M | -1.1 M | |
| Pretax Profit Margin | (19.50) | (20.48) | |
| Operating Profit Margin | (18.17) | (19.08) | |
| Net Loss | (19.50) | (20.48) | |
| Gross Profit Margin | (2.05) | (2.16) |
Other Information on Investing in Burcon Stock
Burcon NutraScience financial ratios help investors to determine whether Burcon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Burcon with respect to the benefits of owning Burcon NutraScience security.